Roche Agrees to Buy Genia Technologies for Up to $350 Million

Roche Holding AG (ROG) agreed to buy Genia Technologies Inc. for as much as $350 million as part of an expansion in the gene-sequencing market.

Roche will pay $125 million in cash and as much as $225 million in further payments based on the achievement of certain goals, the Basel-based company said today in a statement.

“Genia’s proprietary technology is expected to reduce the price of sequencing while increasing speed and sensitivity,” Roche said.

To contact the reporter on this story: Thomas Mulier in Geneva at tmulier@bloomberg.net

To contact the editors responsible for this story: David Risser at drisser@bloomberg.net John Bowker, Kim McLaughlin

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.